↓ Skip to main content

Dove Medical Press

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

Overview of attention for article published in OncoTargets and therapy, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
2 X users
reddit
1 Redditor

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
22 Mendeley